Mainz Biome will present an analysis from its eAArly DETECT study at Digestive Disease Week, DDW, 2024 in Washington D.C. from May 18th to May 21st. DDW is recognized as a premier forum for the latest advancements in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery. eAArly DETECT is a US multi-site study performed at 21 specialized gastroenterology sites that enrolled 254 clinical patients. The results show performance of its multimodal screening test combining Fecal Immunochemical Test, DNA and mRNA biomarkers with a unique artificial intelligence / machine learning algorithm to differentiate between colorectal cancer, advanced adenomas, non-advanced adenomas and patient samples with no findings.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYNZ:
- Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
- Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
- Mainz Biomed reports topline results from pooled study of mRNA biomarkers
- Mainz Biomed Announces Upcoming Annual Meeting
- Mainz Biomed Secures New Funding Agreement